nav-left cat-right
cat-right

U.S. domination of global biomedical R&D slip...

Big Pharma’s decision to shift more of its R&D resources to Asia over the past few years has helped spur a subtle but significant erosion of the U.S.’s traditional dominance in the field. New research from the University of Michigan Health System shows that the U.S. share of the global biomedical R&D business declined to 45%–from 51%–between 2007 and 2012. And while Europe stayed steady at 29%,...

Venus gets Innovative 100 Award for Elores

Chandigarh, December 23 2013: Venus Remedies Limited, a leading research-based global pharmaceutical company, has received the “Innovative 100 Award” for its novel research product Elores, a drug designed to fight superbugs against which other antibiotics fail to respond, at an award function organized by “Inc India”, a business magazine, in New Delhi. After receiving the award, Mr Pawan Chaudhary, Chairman and...

Pneumonia and Diarrhea continue to be the leading ...

New Progress Report finds that India continues to have low coverage levels for prevention and treatment interventions for these easily preventable diseases New Delhi, 12 November, 2013 – The Pneumonia and Diarrhea Progress Report 2013 published by the International Vaccine Access Center (IVAC) at Johns Hopkins Bloomberg School of Public Health today highlights that India continues to have the largest pneumonia and diarrheal...

Chemie Uzbekistan 2011

The 5th Anniversary Central Asian International exhibition «Chemical industry – Chemie Uzbekistan» and the 2nd Uzbek International exhibition of plastics and rubber – «Plastex Uzbekistan 2011» will be held from the 16th till the 18th of November 2011, at the Pavilion 1 of OJSS «Uzexpocentre». “ITE UZBEKISTAN” is the organizer of the exhibitions The exhibitions will feature the following...

Clinical Trials in Asia Summit 2009

4th Annual Pharmacovigilance Conference Determining the prospective strategies for Implementing Clinical trials in India & South Asia – Today’s Hottest Market 18th – 20th May 2009, The Park, New Delhi, India   Key Speakers • Chandrashekhar Potkar, Director, Medical and Regulatory Affairs, Pfizer, India • Viraj Rajadhyaksha, Senior Manager, Operations, Planning & Mgmt...

Institute of Microbiology of the Chinese Academy o...

BEIJING & NEW YORK–(BUSINESS WIRE)–The Institute of Microbiology (IMCAS), a member institute of the Chinese Academy of Sciences, and the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of new TB drugs, today announced a partnership to discover and develop promising,...
Page 1 of 3123